Explore 3 Stock Ideas & Industry Insights Download Free Report

News

iMDx (Nasdaq:IMDX) Begins Patient Enrollment in GraftAssureDx Clinical Trial

Insight Molecular Diagnostics, Inc. (Nasdaq:IMDX) announced that it has begun actively enrolling patients in its clinical trial to evaluate GraftAssureDx, its next-generation kitted transplant rejection test. Last week, the first patient was enrolled, marking a key milestone in the study. The official clinical trial …

Team Kalkine | 08 September 2025

Swvl Holdings (Nasdaq:SWVL) Achieves 26% Revenue Growth and Net Profit in H1 2025

Swvl Holdings Corp (Nasdaq:SWVL), a global provider of tech-enabled mass transit solutions, announced its financial results for the first half of 2025, demonstrating growth and improved profitability across its operations. Total IFRS revenue for H1 2025 reached $10.19 million, representing a 26% increase from …

Team Kalkine | 08 September 2025

Global Markets Update: Stocks, Commodities, Tariffs, and Fed Outlook

U.S. stocks hit record highs early Friday but reversed lower after weak August jobs data fueled worries about an economic slowdown. The Dow fell 0.48%, the S&P 500 lost 0.32%, and the Nasdaq slipped 0.03%. Markets remain confident of a 25 bps Fed rate …

Team Kalkine | 08 September 2025

From Crisis Hedge to $5,000: Can Gold’s Bull Run Go the Distance?

Gold has always been more than just a metal. It is a symbol of wealth, a store of value, and a refuge when trust in financial systems falters. For centuries, gold has preserved purchasing power when currencies failed, governments collapsed, or wars ravaged economies. …

Team Kalkine | 08 September 2025

What Could Drive the Next Move for NVIDIA (NASDAQ: NVDA) in 2025?

NVIDIA Corp. (NASDAQ: NVDA) remains one of the most closely watched equities in the U.S. market. As of the latest trade, NVDA shares trade atUSD 167.02, downUSD 4.75 (-0.03%)from the previous close. The session opened at USD 167.89, hit an intraday high of USD …

Team Kalkine | 08 September 2025

Palisade Bio (NASDAQ:PALI) Receives Health Canada Clearance for Phase 1b Study of PALI-2108 in Crohn’s Disease

Palisade Bio, Inc. (NASDAQ:PALI), a clinical-stage biopharmaceutical company developing therapies for autoimmune, inflammatory, and fibrotic diseases, announced that it has received a No Objection Letter (NOL) from Health Canada for its Clinical Trial Application. The approval allows the company to advance PALI-2108, a first-in-class …

Team Kalkine | 07 September 2025

Semtech (NASDAQ:SMTC) Expands FiberEdge Portfolio with New Power-Efficient TIAs for AI Infrastructure

Semtech Corporation (NASDAQ:SMTC), a provider of high-performance semiconductors, Internet of Things (IoT) systems, and cloud connectivity services, announced the launch of two new FiberEdge® transimpedance amplifiers (TIAs) aimed at addressing power efficiency challenges in scaling AI infrastructure.

Team Kalkine | 07 September 2025

Record Highs for Stocks, Commodities Diverge, Fed Cut Bets Strengthen

Index Update:U.S. stocks closed higher, with the S&P 500 hitting a new record, as weak private payrolls and rising jobless claims reinforced expectations of a Fed rate cut this month. Broadcom jumped after reporting strong earnings, issuing upbeat guidance, and announcing $10 billion in …

Team Kalkine | 05 September 2025

Tech Gains, Commodities Slide, Job Cuts Rise, and Fed Outlook in Focus

U.S. stocks were mixed as the S&P 500 and Nasdaq rose on strong tech gains, led by Alphabet and Apple, while the Dow edged lower. Despite the rally, worries over weakening labor demand persisted, keeping attention on upcoming payrolls and jobless claims data.

Team Kalkine | 04 September 2025

AC Immune (NASDAQ: ACIU) Restructures Operations, Cuts Workforce to Extend Cash Runway

AC Immune SA (NASDAQ: ACIU) has announced a strategic restructuring aimed at streamlining operations and concentrating resources on its highest-value programs. The plan includes a 30% workforce reduction and a narrowed focus on three clinical-stage active immunotherapy programs, along with small molecule programs targeting …

Team Kalkine | 04 September 2025
Support

Hi! How can we help you today?

Loading…